AzurRx BioPharma, Inc.
AzurRx BioPharma, Inc. (AZRX) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
azrx · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for AzurRx BioPharma, Inc. (AZRX) measures how much investors pay for each dollar of the company's trailing earnings. AZRX's current PE ratio of N/A is calculated by dividing its stock price of $3.45 by its TTM earnings per share of -$1.96.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2015 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Biotechnology · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
AzurRx BioPharma, Inc.You AZRX | $3M | N/A | — | -$1.96 |
 Atreca, Inc. BCEL | $4M | N/A | — | -$2.52 |
 Altamira Therapeutics Ltd. CYTO | $1M | N/A | — | $0.00 |
 Gritstone bio, Inc. GRTS | $4M | N/A | — | -$1.20 |
 Idera Pharmaceuticals, Inc. IDRA | $0M | N/A | — | -$7.17 |
 Lisata Therapeutics, Inc. LSTA | $31M | N/A | — | -$1.91 |
 Onconetix, Inc. ONCO | $0M | N/A | — | -$4.28 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | — | $-4.05 | — | |
2024-12-31 FY2024 | — | $-5.26 | — | |
2020-12-31 FY2020 | — | $-5.90 | — | |
2019-12-31 FY2019 | — | $-6.77 | — | |
2018-12-31 FY2018 | — | $-8.77 | — | |
2017-12-31 FY2017 | — | $-10.44 | — | |
2016-12-31 FY2016 | — | $-14.96 | — | |
2015-12-31 FY2015 | — | $-6.16 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for AzurRx BioPharma, Inc. (AZRX) measures how much investors pay for each dollar of the company's trailing earnings. AZRX's current PE ratio of N/A is calculated by dividing its stock price of $3.45 by its TTM earnings per share of -$1.96.
Frequently asked questions
AZRX pe ratio · 6 questionsAZRX's current PE ratio is N/A as of 2026-06-09, based on a stock price of $3.45 and TTM EPS of -$1.96. Data sourced from Financial Modeling Prep via AZRX's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · AzurRx BioPharma, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09